Icecure Medical Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.4M+2.7% YoYTTM through 31 Dec 2025
Net Income -$15.1MTTM through 31 Dec 2025
Free Cash Flow -$14.6MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 36.3% |
| EBITDA Margin | -438.0% |
| Operating Margin | -446.7% |
| Net Margin | -445.6% |
Returns
-166.4%ROE
-108.4%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio2.61x
Net Debt-$8.9Mnet cash position
Cash & Equivalents$8.9M
Quality Metrics
Altman Z-Score-13.98
Piotroski F-Score5 / 9
FCF Margin-432.4%
Rule of 40-398.3
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $3.4M
Diluted EPS-$0.24TTMFY2025: $0.24
Dividend
No dividend
Capital Allocation
Capex Intensity1.1%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.